• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-09-20

  The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, supports reproducible detection of HMGB1 in human, mouse, and rat research samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled scientific workflows only, with no diagnostic, therapeutic, or directly matched paper evidence asserted here.

• SERCA2–CaN–FoxO1–FABP4 Signaling in Atherosclerosis

  2026-09-19

  This study identifies a mechanistic link between SERCA2 dysfunction, calcineurin/FoxO1 signaling, FABP4 induction, and macrophage foam cell formation. Its genetic and pharmacological experiments suggest that interrupting this pathway can correct lipid abnormalities and reduce atherosclerotic lesion development.

• From FUS Condensates to Translational Control

  2026-09-18

  A mechanistic and strategic analysis of how arginine methylation, SMN valency, and FUS phase separation reshape neuronal granule research—and how translational teams can convert these insights into disciplined experimental workflows.

• BV6 IAP Antagonist: Applied Research Workflows

  2026-09-18

  BV6 is a Smac-mimetic IAP antagonist for building apoptosis, chemotherapy-sensitization, and radiosensitization experiments in cancer models. This practical guide connects dose planning, cell-death phenotyping, and troubleshooting with the reference study’s important distinction between reduced RIPK3 abundance and direct inhibition of necroptosis.

• Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow

  2026-09-17

  Build sensitive human IgG readouts across immunofluorescence, tissue imaging, flow cytometry, and ELISA with a Cy3 conjugated secondary antibody. This practical guide connects assay design, quantified starting conditions, controls, and troubleshooting to antibody-engineering research without overstating what the reagent can prove.

• Pterostilbene, Mitochondrial Quality, and Dermal Senescence

  2026-09-17

  Zhou et al. show that pterostilbene reduces senescence in human dermal fibroblasts exposed to UVB-associated oxidative stress or replicative aging. The study links this effect to improved mitochondrial morphology, membrane potential, respiration, and mitophagy, with supporting evidence from a UVB-exposed mouse model.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-09-16

  Navazesh and Ji show that iron deficiency and iron excess produce distinct transcriptional and metabolic states in IPEC-J2 enterocytes. Their combined gene-expression, inflammatory-challenge, proliferation, and untargeted-metabolomics design clarifies how iron availability influences intestinal epithelial resilience and recovery after iron repletion.

• Dasatinib (BMS-354825) Experimental Workflows

  2026-09-16

  Build reproducible kinase-signaling experiments with Dasatinib, from Src and Bcr-Abl pathway interrogation to phospho-FAK assays and translational cancer models. This guide connects validated product-use conditions with the SNAI1–PIK3R2/p-EphA2 findings in thymic tumors while clearly separating evidence from testable hypotheses.

• Azilsartan Medoxomil Monopotassium in Translation

  2026-09-15

  Azilsartan medoxomil monopotassium, also known as TAK 491 monopotassium, offers translational researchers a tightly defined way to interrogate AT1 receptor biology across molecular, preclinical, and clinical research. This article connects receptor kinetics, experimental design, meta-analytic evidence, and strategic study planning for hypertension and cardiovascular disease research.

• Nintedanib: Genotype-Aware Research Design

  2026-09-15

  Nintedanib (BIBF 1120) is a multi-target angiokinase inhibitor with value beyond conventional antiangiogenic screening. This article presents an ATRX-informed framework for connecting receptor coverage, assay design, and translational interpretation across cancer and fibrosis research.

• VIK–Auxin Signaling in Arabidopsis Lateral Roots

  2026-09-14

  The reference study identifies the auxin-activated kinase VIK as a phosphorylation-based regulator of lateral root development in Arabidopsis. Its central contribution is a dual mechanism in which VIK stabilizes the positive regulator LBD18 while promoting degradation of the repressor ERF13, linking auxin signaling to coordinated control of protein stability.

• Rapid Microwave Heating Preserves Lactoferrin

  2026-09-14

  The reference study shows that heating rate, rather than a distinct microwave dielectric effect, is the dominant factor preserving lactoferrin structure and bioactivity during treatment at 70–90 °C. By comparing microwave, conventional thermal, and microwave-simulated conventional heating, the authors connect rapid passage through the denaturation range with reduced aggregation and retention of antioxidant, anti-inflammatory, and anti-apoptotic functions.

• RBM3, MEF2C, and BBB Integrity in Alzheimer’s Disease

  2026-09-13

  The reference study identifies an RBM3–MEF2C regulatory axis that links post-transcriptional mRNA stabilization to tight-junction gene expression and blood–brain barrier permeability in an Alzheimer’s disease microenvironment. Its combination of RNA-binding, transcriptional, and barrier-function assays provides a mechanistic framework for studying how amyloid-β-associated endothelial stress weakens the BBB.

• Niclosamide: STAT3 Mechanism and Research Workflow

  2026-09-12

  Niclosamide is a small-molecule STAT3 pathway inhibitor with a reported IC50 of 0.7 μM. It inhibits STAT3 Tyr-705 phosphorylation, supports mechanistic cancer research, and has documented activity in Du145 cells and an HL-60 xenograft model.

• Caveolin-1 Restores Cholesterol Homeostasis in MASLD

  2026-09-11

  The reference study identifies caveolin-1 as a regulator of hepatic cholesterol homeostasis whose loss intensifies endoplasmic reticulum stress and pyroptosis during MASLD. By combining CAV1-deficient mice, liver transcriptomics, human samples, and in vitro validation, the authors connect CAV1 with the FXR/NR1H4–ABCG5/ABCG8 pathway and provide a mechanistic framework for studying cholesterol-driven liver injury.

8457 records 1/564 page Next 12345 下5页 Last page